8-K: Cigna Group Reports Strong Q3 2024 Results, Reaffirms Full-Year Outlook

The Cigna Group announced a 30% increase in total revenue for the third quarter of 2024, reaching $63.7 billion, and reaffirmed its adjusted EPS outlook for the year.

Summary

• The Cigna Group reported a strong third quarter for 2024, with total revenues increasing by 30% to $63.7 billion compared to the same period in 2023.
• Shareholders' net income for the quarter was $0.7 billion, or $2.63 per share, which includes a non-cash after-tax investment loss of $1.0 billion related to VillageMD.
• Adjusted income from operations for the third quarter was $2.1 billion, or $7.51 per share, a 5% increase compared to the third quarter of 2023.
• The company's Evernorth Health Services segment saw a 36% increase in adjusted revenues and a 9% increase in adjusted income from operations, pre-tax.
• Pharmacy Benefit Services within Evernorth experienced a 50% increase in adjusted revenues, while Specialty and Care Services saw a 23% increase in both adjusted revenues and adjusted income from operations, pre-tax.
• Cigna Healthcare's adjusted revenues increased by 3%, while adjusted income from operations, pre-tax, decreased by 4%.
• Total customer relationships increased by 12% to 183.5 million, and total pharmacy customers increased by 22% to 120 million.
• The company reaffirmed its 2024 outlook for adjusted income from operations of at least $28.40 per share.

Sentiment

Score: 7

Explanation: The overall sentiment is positive due to strong revenue growth and reaffirmed guidance, but there are some concerns about the decrease in net income and the increase in the medical care ratio.

Positives

• The Cigna Group experienced significant revenue growth, with a 30% increase in total revenues for the third quarter of 2024.
• Adjusted income from operations increased by 5% year-over-year, indicating improved profitability.
• Evernorth Health Services demonstrated strong performance, with substantial growth in both revenue and income.
• The company saw a significant increase in customer relationships, with a 12% increase overall and a 22% increase in pharmacy customers.
• The SG&A expense ratio improved, reflecting business mix shift, strong revenue growth, and continued operating efficiency.
• The company reaffirmed its full-year adjusted EPS outlook, indicating confidence in future performance.

Negatives

• Shareholders' net income decreased compared to the same quarter last year, primarily due to a non-cash after-tax investment loss of $1.0 billion related to VillageMD.
• Cigna Healthcare's adjusted income from operations, pre-tax, decreased by 4% year-over-year.
• Cigna Healthcare's Medical Care Ratio (MCR) increased to 82.8% from 80.5% in the prior year, indicating higher medical costs.
• Net investment income for Evernorth Health Services decreased to $40 million from $63 million in the prior year.

Risks

• The company's net income was negatively impacted by a $1.0 billion non-cash after-tax investment loss related to VillageMD.
• Cigna Healthcare experienced a decrease in adjusted income from operations, pre-tax, and an increase in the Medical Care Ratio (MCR), indicating potential challenges in managing medical costs.
• The company's performance is subject to various risks and uncertainties, including changes in the healthcare industry, competition, and regulatory environments.
• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied.

Future Outlook

The Cigna Group reaffirmed its 2024 outlook for adjusted income from operations of at least $28.40 per share, including the impact of expected future share repurchases and anticipated 2024 dividends.

Management Comments

• David M. Cordani, chairman and CEO of The Cigna Group, stated that the strong performance this quarter is a testament to the leadership, stability and expertise of the team.
• Cordani also noted that the company's disciplined execution of its strategic plan and comprehensive health services ensure they remain well-positioned in a highly dynamic environment.

Industry Context

This announcement reflects the ongoing trends in the healthcare industry, including the growth of pharmacy benefit services and the increasing focus on specialty care. The results also highlight the competitive pressures in the health insurance market, as seen in the increased medical care ratio for Cigna Healthcare.

Comparison to Industry Standards

• Cigna's 30% revenue growth in Q3 is strong compared to peers like UnitedHealth Group and Humana, which have also reported growth but not at this rate.
• The 5% increase in adjusted income from operations is solid, but the decrease in Cigna Healthcare's profitability is a concern compared to other large insurers.
• The increase in the Medical Care Ratio (MCR) to 82.8% is higher than some competitors, indicating potential cost management challenges.
• Cigna's expansion in pharmacy customers by 22% is a positive sign, outpacing some competitors in this area.

Stakeholder Impact

• Shareholders will be impacted by the increase in revenue and adjusted income from operations, but also by the decrease in net income due to the VillageMD investment loss.
• Customers may benefit from the company's continued expansion of services and customer relationships.
• Employees may be impacted by the company's focus on growth and efficiency.

Next Steps

• The company will host a conference call to review third quarter 2024 results and discuss the full year 2024 outlook.
• The company will continue to execute its strategic plan and focus on business growth in both the nearand long-term.

Key Dates

Keywords

Cigna, Healthcare, Evernorth, Pharmacy Benefit Services, Specialty Care Services, Financial Results, Adjusted Income, Revenue, Medical Care Ratio, Customer Relationships